PRE PRENETICS GLOBAL LIMITED

Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours

Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours

Up to 733% Greater Potency Across 11 Key Nutrients, Including New Saffron Nootropic and Bioactive Vitamin Forms

Two New Flavours — Mango + Passionfruit and Lemon + Orange

Same Price for New and Existing Customers

Full Supplement Facts Available at

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced the launch of Daily Ultimate Essentials PRO, a new clinical-grade version of its flagship daily health supplement under the IM8 Health brand. Alongside the reformulated product, Prenetics is also introducing two new flavours — Mango + Passionfruit and Lemon + Orange — expanding the range to meet growing consumer demand for variety.

Daily Ultimate Essentials has already earned over 10,000 five-star reviews, more than 670,000 customer purchases, and over 20 million servings served since its initial launch. The PRO formula represents the next evolution of the product, incorporating the latest advances in nutritional science to deliver clinical-grade potency, superior bioavailability, and a new cognitive support ingredient — all while maintaining the same price for both new and existing customers.

Key Advances in the PRO Formula

The PRO formula has been engineered across multiple dimensions to deliver clinical-grade nutritional impact:

Active IngredientOriginalPROChangeKey Benefit
Vitamin B12 (Methylcobalamin)24mcg200mcg+733%Cellular energy
Cell Renewal (CRT8™)25mg100mg+300%Cellular rejuvenation
Vitamin K2 (Menaquinone-7)40mcg100mcg+150%Arterial & bone health
Vitamin D3 (VegD3® Lichen)30mcg50mcg+67%Immune support
Choline (Choline Bitartrate)35mg55mg+57%Focus & memory
Magnesium (Bisglycinate Chelate)65mg100mg+54%Relaxation & recovery
Joint Support (MSM)1,000mg1,500mg+50%Clinical-grade mobility
Amino Complex1,165mg1,580mg+36%Tissue repair
Saffron Extract30mgNEWMood & cognitive clarity
Vitamin B6 (P5P)Pyridoxine HClPyridoxal 5’-PhosphateUpgradeBioactive absorption
Riboflavin (R5P)StandardRiboflavin-5’-PhosphateUpgradeMetabolic efficiency
     



The PRO formula also features Vitamin B6 in its bioactive form, Pyridoxal 5-Phosphate (P5P), and Riboflavin as Riboflavin-5-Phosphate (R5P). These active forms bypass common genetic conversion barriers, ensuring superior absorption and more efficient nutrient utilisation across the body.

The full supplement facts and ingredients panel is available at:

Two New Flavours: Mango + Passionfruit & Lemon + Orange

Responding to customer feedback and a desire for greater variety, Prenetics is also expanding the Daily Ultimate Essentials PRO range with two new flavour options: Mango + Passionfruit and Lemon + Orange. Both new flavours contain the full PRO formula and are designed to make the daily health ritual even more enjoyable. They join the existing flavour lineup, giving consumers more choice without any compromise on the product’s comprehensive nutritional profile.

“The PRO formulation isn’t just an update; it’s an evolution. By upgrading to bioactive forms like P5P and significantly increasing key dosages like B12, MSM and Vitamin D, we are delivering a level of cellular support that is rarely seen in a single product. This is clinical-grade nutrition, optimised for real-world performance.”

  • Dr. Dawn Mussallem, Chief Medical Officer at Fountain Life; Integrative Oncologist, Mayo Clinic; IM8 Scientific Advisory Board Member

Danny Yeung, Chief Executive Officer and Co-Founder of Prenetics, commented: “When we launched Daily Ultimate Essentials, we set out to create the most comprehensive daily health formula on the market. With PRO, we’re raising that bar again. The addition of premium ingredients like saffron extract, the massive increase in key nutrient dosages, and the introduction of Mango + Passionfruit and Lemon + Orange flavours reflect our commitment to continuous improvement and listening to our community. And we’re doing all of this at no extra cost — the PRO formula is available at the same price for both new and existing customers, because better health should be accessible to everyone.”

Existing IM8 subscribers will be automatically upgraded to the PRO formula with their next scheduled delivery at no additional cost. No action is required. New customers will also receive the PRO formula at the same price as the original. The PRO formula remains vegan, gluten-free, dairy-free, and non-GMO.

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company’s flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 30 countries worldwide.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit

Investor Relations Contact:

 

 

Angela Cheung

Investor Relations / Corporate Finance

 



EN
23/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PRENETICS GLOBAL LIMITED

 PRESS RELEASE

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmp...

Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership Giannis becomes the first NBA athlete shareholder in a NASDAQ-listed health and longevity brand, joining the fastest supplement company ever to reach $100M ARR in just 11 months Giannis unlocks 35 million followers across social channels - NBA broadcasted in 215 countries To learn more about Giannis and IM8, please visit NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), the parent comp...

 PRESS RELEASE

Prenetics' IM8 Partners with Superpower to Personalize the Future of S...

Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protocols. NEW YO...

 PRESS RELEASE

Prenetics to Participate in the 38th Annual ROTH Conference

Prenetics to Participate in the 38th Annual ROTH Conference NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the Company will participate in the 38th Annual ROTH Conference being held Sunday, March 22nd to Tuesday, March 24th at the Ritz-Carlton in Laguna Niguel, CA. Prenetics CEO Danny Yeung and President of Americas David Vanderveen will be available for one-on-one meetings throughout the conference. Management w...

 PRESS RELEASE

Prenetics Authorizes $40 Million Share Repurchase Program

Prenetics Authorizes $40 Million Share Repurchase Program Management and Board Have Collectively Committed Up to $42.75 Million to Prenetics Stock Backed by $164 Million in Total Adjusted Liquidity, Zero Debt IM8 Targeting $180M to $200M in 2026 Full Year Revenue, and a Clear Path to Adjusted EBITDA Profitability by Q4 2027 NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that its Board of Directors (the “B...

 PRESS RELEASE

Prenetics Executives Execute Second Consecutive Round of Post-Earnings...

Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million -  CEO Danny Yeung makes personal investment in this round of approximately $750,000, up from investment of approximately $502,000 in November 2025 NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced that members of its execu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch